Singapore Market Roundup, Singapore Market Roundup

Singapore Market Roundup

Thematic (Sector/Industry)

<ul><li>DBS downgrades SGX to 'hold' as growth shows signs of tapering off.</li><li>uSmart upgrades Hong Leong Asia to 'buy' following strong 1HFY2026 results.</li><li>uSMART starts ‘buy’ on Toku, setting a target price of 15.1 cents.</li></ul>

DBS downgrades SGX to 'hold' as growth shows signs of tapering off.uSmart upgrades Hong Leong Asia to 'buy' following strong 1HFY2026 results.uSMART starts ‘buy’ on Toku, setting a target price of 15.1 cents.

Singapore Market Roundup (13-Oct-2026): DBS downgrades SGX to 'hold' amid slowing growth.

<ul>
<li>CGSI has a positive outlook on Sembcorp.                                        </li>
<li>Maybank downgrades Sheng Siong to 'hold' with reduced target price.</li>
<li>DBS keeps 'buy' rating on Singtel amid Airtel's postpaid price hike.</li>
</ul>


CGSI has a positive outlook on Sembcorp.                                        
Maybank downgrades Sheng Siong to 'hold' with reduced target price.
DBS keeps 'buy' rating on Singtel amid Airtel's postpaid price hike.


Singapore Market Roundup (09-Oct-2026): CGSI is optimistic about Sembcorp.

<ul><li>UOBKH maintains 'buy' on United Hampshire US REIT amid retail sector revival.</li><li>Phillip Securities initiates 'buy' rating for JEP at 83 cents.</li><li>JP Morgan recommends reducing DBS and OCBC holdings, favoring UOB instead.</li></ul>

UOBKH maintains 'buy' on United Hampshire US REIT amid retail sector revival.Phillip Securities initiates 'buy' rating for JEP at 83 cents.JP Morgan recommends reducing DBS and OCBC holdings, favoring UOB instead.

Singapore Market Roundup (08-Oct-2026): UOBKH keeps 'buy' on United Hampshire US REIT as retail

<ul><li>RHB sees Raffles Medical's 52-week low as a buying opportunity.</li><li>Citi starts 'buy/high risk' rating on SMID global leader CSE Global.</li><li>Maybank's Seet is bullish on Frencken, lowers target price after $100M placement.</li></ul>

RHB sees Raffles Medical's 52-week low as a buying opportunity.Citi starts 'buy/high risk' rating on SMID global leader CSE Global.Maybank's Seet is bullish on Frencken, lowers target price after $100M placement.

Singapore Market Roundup (10-Sep-2026): RHB views Raffles Medical's 52-week low as a buy signal.

<ul><li>Maybank’s Seet stays positive on Frencken, lowers target price post $100M placement.</li><li>UOBKH cuts Delfi's target price due to rising cocoa prices and forex issues.</li><li>Maybank's Seet keeps 'buy' rating with 24-cent target on Marco Polo Marine post-RTO.</li></ul>

Maybank’s Seet stays positive on Frencken, lowers target price post $100M placement.UOBKH cuts Delfi's target price due to rising cocoa prices and forex issues.Maybank's Seet keeps 'buy' rating with 24-cent target on Marco Polo Marine post-RTO.

Singapore Market Roundup (09-Sep-2026): Maybank's Seet lowers Frencken target price after $100M

Malaysia

Malayan Banking Berhad operates as a bank. The Company provides financial services such as insurance, asset management, stock broking, nominee services, venture capital, leasing, and Internet banking. Malayan Banking Berhad serves customers in South East Asia.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Maybank (MAY MK)

Singapore Market Roundup (13-Oct-2026): DBS downgrades SGX to 'hold' amid slowing growth.

DBS downgrades SGX to 'hold' amid slowing growth; uSMART upgrades Hong Leong Asia to 'buy' after strong 1HFY2026 results and starts 'buy' on Toku...

Singapore Market Roundup

Singapore Market Roundup (09-Oct-2026): CGSI is optimistic about Sembcorp.

CGSI is optimistic about Sembcorp. Maybank downgrades Sheng Siong to 'hold' with a lower target price, while DBS maintains a 'buy' rating on Singtel.

Singapore Market Roundup

Singapore Market Roundup (08-Oct-2026): UOBKH keeps 'buy' on United Hampshire US REIT as retail

UOBKH keeps 'buy' on United Hampshire US REIT; Phillip Securities starts 'buy' on JEP at 83 cents; JP Morgan advises reducing DBS and OCBC, prefers...

Singapore Market Roundup

Singapore Market Roundup (10-Sep-2026): RHB views Raffles Medical's 52-week low as a buy signal.

RHB views Raffles Medical's 52-week low as a buying chance. Citi gives a 'buy/high risk' rating to CSE Global, while Maybank's Seet is bullish on...

Singapore Market Roundup

Singapore Market Roundup (09-Sep-2026): Maybank's Seet lowers Frencken target price after $100M

Maybank's Seet remains positive on Frencken despite lowering the target price after a $100M placement. UOBKH cuts Delfi's target price amid cocoa...

Singapore Market Roundup

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)